Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Late cornified envelope protein 5A (LCE5A) is a structural protein encoded by the LCE5A gene, located in the epidermal differentiation complex on human chromosome 1. LCE5A is grouped with other late cornified envelope (LCE) proteins, which contribute to the formation and maturation of the cornified envelope, a key component of the skin’s protective barrier. Expression of LCE5A, like other LEP cluster proteins, increases late in terminal differentiation of keratinocytes, after other major structural components such as loricrin. LCE5A is predicted to play roles in keratinization and skin barrier integrity. The protein responds to environmental signals, such as calcium and ultraviolet irradiation, which may affect skin adaptation and function. There is no evidence LCE5A acts as a receptor, enzyme, or transporter, nor is it currently considered a drug target or biomarker. While mutations and copy number changes are observed in population datasets, no definitive disease associations or safety concerns have been described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Late cornified envelope protein 5A (LCE5A).